Kevin P. Bateman - Concepedia

Author

Kevin P. Bateman

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Bateman, K.P., K Bateman, K.P Bateman, K.P. Bateman, KP Bateman, Kevin Bateman, Kevin P Bateman, Kevin P. Bateman, Kevin P. Bateman, Kim Bateman

113

Publications

4.8K

Citations

H-Index

117

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Merck Canada Inc. (Canada)United States Military Academy TransCanada (Canada)Institute for Marine Biosciences

About

Kevin P. Bateman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, bioanalysis, and analytical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	33	1.7K
2	Natural Sciences	13	16	695
3	Engineering	10	10	502
4	Health Sciences	2	2	25
5	Public Health	2	2	66

Kevin P. Bateman

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules A. Buitrago Santanilla, Erik L. Regalado, Tony Pereira, Science	2014	635
Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1 Jocelyne Guay, Kevin P. Bateman, Robert J. Gordon, Journal of Biological Chemistry	2004	265
MS <sup>E</sup> with mass defect filtering for <i>in vitro</i> and <i>in vivo</i> metabolite identification Kevin P. Bateman, José Castro‐Perez, Mark Wrona, Rapid Communications in Mass Spectrometry	2007	254
Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer Kevin P. Bateman, Markus Kellmann, Helmut Muenster, Journal of the American Society for Mass Spectrometry	2009	193
‘All‐in‐One’ analysis for metabolite identification using liquid chromatography/hybrid quadrupole time‐of‐flight mass spectrometry with collision energy switching Mark Wrona, Timo Mauriala, Kevin P. Bateman, Rapid Communications in Mass Spectrometry Biological Mass SpectrometryMetabolomic ProfilingDrug Discovery EnvironmentGas ChromatographyBioanalysis	2005	173
Discovery of a Potent and Selective Prostaglandin D<sub>2</sub> Receptor Antagonist, [(3<i>R</i>)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indol-3-yl]-acetic Acid (MK-0524) Claudio F. Sturino, Gary P. O’Neill, Nicolas Lachance, Journal of Medicinal Chemistry	2007	170
γ-Aminobutyric Acid Type B Receptors with Specific Heterodimer Composition and Postsynaptic Actions in Hippocampal Neurons Are Targets of Anticonvulsant Gabapentin Action Gordon Ng, Sandrine S. Bertrand, Richard Sullivan, Molecular Pharmacology	2001	143
Discovery stage pharmacokinetics using dried blood spots Patrick Beaudette, Kevin P. Bateman Journal of Chromatography B MedicineBioanalysisPharmacologyChromatographyLaboratory Medicine	2004	134
Mass spectral analyses of microcystins from toxic cyanobacteria using on-line chromatographic and electrophoretic separations Kevin P. Bateman, Pierre Thibault, D. J. Douglas, Journal of Chromatography A Mass Spectral AnalysesGas ChromatographyBioanalysisMass SpectrometryAnalytical Chemistry	1995	126
Deletion of Microsomal Prostaglandin E2 (PGE2) Synthase-1 Reduces Inducible and Basal PGE2 Production and Alters the Gastric Prostanoid Profile Louise Boulet, Marc Ouellet, Kevin P. Bateman, Journal of Biological Chemistry	2004	118

Page 1